Ifosfamide/Vindesine Chemotherapy in Primarily Resistant or Relapsed Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology - Germany
doi 10.1007/bf02579912
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Karnofsky-Adapted Chemotherapy of Non Small Cell Lung Cancer (NSCLC) With Ifosfamide/Mitomycin C/Vindesine

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Pilot Study of Alternating Radiotherapy and Three-Drug Combined Chemotherapy Consisting of Ifosfamide, Cisplatin and Vindesine in Localized Inoperable Non-Small Cell Lung Cancer.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1993English

Chemotherapy in Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1990English

Rechallenge With First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer

Case Reports in Oncology
Oncology
2018English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

Research in Oncology
2007English

P3.01-082 Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

Cancer Research and Treatment
Cancer ResearchOncology
2004English

Cisplatin, Vindesine, and Concomitant Radiation Therapy for Unresectable Non-Small Cell Lung Cancer.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy